INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE

INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE

Show other versions (1)

Detalhes bibliográficos
Main Authors:	Moots, R, Young, S, Strominger, J, Frelinger, J, Bacon, P, Mcmichael, A
Formato:	Journal article
Publicado em:	1993

Registos relacionados

INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE
Por: Moots, R, et al.
Publicado em: (1993)

A cross-species functional interaction between the murine major histocompatibility complex class I alpha 3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytes.
Por: Moots, R, et al.
Publicado em: (1992)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
Por: Matsui, M, et al.
Publicado em: (1994)

Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders
Por: Masha Fridkis-Hareli
Publicado em: (2013-01-01)

Different MHC class I alleles compete for presentation of overlapping viral epitopes.
Por: Tussey, L, et al.
Publicado em: (1995)

MHC class II proteins and disease: a structural perspective.
Por: Jones, E, et al.
Publicado em: (2006)

MHC class II proteins and disease: a structural perspective
Por: Jones, E, et al.
Publicado em: (2006)

A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
Por: Moots, R, et al.
Publicado em: (1991)

Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
Por: Matsui, M, et al.
Publicado em: (1995)

Evidence of widespread binding of HLA class I molecules to peptides.
Por: Frelinger, J, et al.
Publicado em: (1990)

Functions of nonclassical MHC and non-MHC-encoded class I molecules.
Por: Braud, V, et al.
Publicado em: (1999)

CTLs target Th cells that acquire bystander MHC class I-peptide complex from APCs.
Por: Cox, J, et al.
Publicado em: (2007)

Production and crystallization of MHC class I B allele single peptide complexes.
Por: Reid, S, et al.
Publicado em: (1996)

A METHOD TO MEASURE MHC CLASS-I-PEPTIDE INTERACTIONS AT THE CELL-SURFACE
Por: Ljunggren, H, et al.
Publicado em: (1990)

THERMODYNAMICS OF PEPTIDE-MHC CLASS II INTERACTIONS: NOT ALL COMPLEXES ARE CREATED EQUAL
Por: Andrea eFerrante
Publicado em: (2013-10-01)

Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC
Por: Hoerter, John A. H., et al.
Publicado em: (2014)

Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent.
Por: Whelan, J, et al.
Publicado em: (1999)

MHC class II regulation of CD8+ T cell tolerance and implications in autoimmunity and cancer immunotherapy
Por: Xiaojuan Zhou, et al.
Publicado em: (2023-11-01)

DIFFERENCES IN PEPTIDE PRESENTATION BETWEEN B27 SUBTYPES - THE IMPORTANCE OF THE P1 SIDE-CHAIN IN MAINTAINING HIGH-AFFINITY PEPTIDE BINDING TO B-ASTERISK-2703
Por: Colbert, R, et al.
Publicado em: (1994)

Re-evaluating the peptide repertoire of MHC-E
Por: S. Brackenridge, et al.
Publicado em: (2017-12-01)

Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
Por: Kasper Winther Jørgensen, et al.
Publicado em: (2010-12-01)

A Peptide Filtering Relation Quantifies MHC Class I Peptide Optimization
Por: Dalchau, N, et al.
Publicado em: (2011)

A peptide filtering relation quantifies MHC class I peptide optimization
Por: Dalchau, N, et al.
Publicado em: (2011)

A peptide filtering relation quantifies MHC class I peptide optimization.
Por: Dalchau, N, et al.
Publicado em: (2011)

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
Por: Colbert, R, et al.
Publicado em: (1993)

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
Por: Colbert, R, et al.
Publicado em: (1993)

TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
Por: Braud, V, et al.
Publicado em: (1998)

The relationship between MHC−peptide interaction and resistance to virus in chickens
Por: Yuan‐chang Jin, et al.
Publicado em: (2022-03-01)

Model for the peptide-free conformation of class II MHC proteins.
Por: Corrie A Painter, et al.
Publicado em: (2008-06-01)

Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703.
Por: Colbert, R, et al.
Publicado em: (1994)

Properties of MHC class I presented peptides that enhance immunogenicity.
Por: Jorg J A Calis, et al.
Publicado em: (2013-10-01)

Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy.
Por: Sharon M Barth, et al.
Publicado em: (2016-01-01)

A peptide filtering relation quantifies MHC class I peptide optimization.
Por: Neil Dalchau, et al.
Publicado em: (2011-10-01)

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
Por: Schroter Stephanie, et al.
Publicado em: (2011-03-01)

Regulation of MHC Class II-Peptide Complex Expression by Ubiquitination
Por: Kyung Jin eCho, et al.
Publicado em: (2013-11-01)

Prediction of MHC class I binding peptides, using SVMHC
Por: Elofsson Arne, et al.
Publicado em: (2002-09-01)

Peptide Loading on MHC Class I Molecules of Tumor Cells
Por: Loredana Cifaldi, et al.
Publicado em: (2016-09-01)

CapsNet-MHC predicts peptide-MHC class I binding based on capsule neural networks
Por: Mahmood Kalemati, et al.
Publicado em: (2023-05-01)

Dynamically Driven Allostery in MHC Proteins: Peptide-Dependent Tuning of Class I MHC Global Flexibility
Por: Cory M. Ayres, et al.
Publicado em: (2019-05-01)

Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.
Por: Ogg, G, et al.
Publicado em: (2000)